Activation of islet 5-HT 4 receptor regulates glycemic control through promoting insulin secretion-Reference-Cited by-同舟云学术

Activation of islet 5-HT 4 receptor regulates glycemic control through promoting insulin secretion

Published:2016-10 Issue: Volume:789 Page:354-361
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Chen Hui,Hong Feng,Chen Ye,Li Ji,Yao Yuan-Sheng,Zhang Yue,Zheng Li-Fei,Zhu Jin-Xia

Funder

National Natural Science Foundation of China

Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges

Publisher

Elsevier BV

Subject

Pharmacology

Reference29 articles.

1. Mosapride citrate, a 5-HT(4) receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men;Aoki;Endocr. J.,2013

2. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy;Asakawa;Diabetes Res. Clin. Pract.,2003

3. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control;Braden;Aliment. Pharmacol. Ther.,2002

4. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound;Briejer;Eur. J. Pharmacol.,2001

5. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population;Choung;Am. J. Gastroenterol.,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin transporter imaging agent as a probe for β-cells of pancreas;Nuclear Medicine and Biology;2024-03

2. The role of mosapride and levosulpiride in gut function and glycemic control in diabetic rats;Arab Journal of Gastroenterology;2023-05

3. In vivo and in vitro binding of [ ¹²⁵ I]I‐R‐(+)‐TISCH: A dopamine D ₁ receptor ligand for studying pancreatic β‐cell mass;Journal of Labelled Compounds and Radiopharmaceuticals;2022-11-06

4. The serotonergic system dysfunction in diabetes mellitus;Frontiers in Cellular Neuroscience;2022-07-14

5. The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta‐cell mass;Diabetes, Obesity and Metabolism;2022-07-11